Kineret — Cigna
Still’s Disease, Adult Onset (AOSD)
Initial criteria
- Patient is age > 18 years; AND
- Medication is prescribed by or in consultation with a rheumatologist
Reauthorization criteria
- Patient has been established on this medication for at least 6 months; AND
- Patient meets at least ONE of the following: (a) Beneficial clinical response from baseline when assessed by at least one objective measure; OR (b) Improvement in at least one symptom
Approval duration
initial 6 months; reauth 1 year